|
CEP55 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8650003763554E-10 |
| Normal-vs-Stage2 |
4.351800E-04 |
| Normal-vs-Stage3 |
6.25544060994798E-12 |
| Normal-vs-Stage4 |
1.05589999965794E-07 |
| Stage1-vs-Stage2 |
3.151200E-01 |
| Stage1-vs-Stage3 |
1.798770E-03 |
| Stage1-vs-Stage4 |
1.620900E-04 |
| Stage2-vs-Stage3 |
4.308200E-01 |
| Stage2-vs-Stage4 |
5.157700E-03 |
| Stage3-vs-Stage4 |
8.603300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.443000E-04 |
| Normal-vs-Asian |
1.213970E-01 |
| Caucasian-vs-AfricanAmerican |
2.784400E-02 |
| Caucasian-vs-Asian |
3.516400E-01 |
| AfricanAmerican-vs-Asian |
3.258000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33146835171283E-15 |
| Normal-vs-Female |
5.9180438327644E-12 |
| Male-vs-Female |
4.644200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.676800E-03 |
| Normal-vs-Age(41-60Yrs) |
6.99440505513849E-15 |
| Normal-vs-Age(61-80Yrs) |
3.56660256883856E-11 |
| Normal-vs-Age(81-100Yrs) |
3.682600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.144800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.603240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.769800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.751200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.052800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.187420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.795400E-03 |
| Normal-vs-Grade 2 |
5.26967358638331E-12 |
| Normal-vs-Grade 3 |
1.18793863634892E-14 |
| Normal-vs-Grade 4 |
4.16590000051897E-07 |
| Grade 1-vs-Grade 2 |
3.436200E-03 |
| Grade 1-vs-Grade 3 |
3.21199999997468E-06 |
| Grade 1-vs-Grade 4 |
2.14089999999167E-05 |
| Grade 2-vs-Grade 3 |
3.718700E-03 |
| Grade 2-vs-Grade 4 |
2.604300E-04 |
| Grade 3-vs-Grade 4 |
2.555400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.91780002989361E-09 |
| Normal-vs-ccB subtype |
3.13809978003121E-10 |
| ccA subtype-vs-ccB subtype |
1.190720E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62547753035369E-12 |
| Normal-vs-N1 |
5.048300E-04 |
| N0-vs-N1 |
6.318100E-03 |
|
|
